TURKISH JOURNAL OF GASTROENTEROLOGY, vol.28, no.5, pp.361-369, 2017 (SCI-Expanded)
Background/Aims: In recent years, the role of the gut microbiota has emerged in several diseases. Herein we aimed to determine the fecal microbiota, endotoxin levels, and inflammation markers in patients with nonalcoholic steatohepatitis (NASH) and healthy controls.